William Ringo to retire from Pfizer
This article was originally published in Scrip
Pfizer's senior vice-president of worldwide business development, strategy and innovation, William Ringo, is to retire from the company, effective April 30th. He joined Pfizer in April 2008, after a 28-year tenure at Lilly. Mr Ringo will be succeeded by Kristin Peck, who most recently played a leadership role in the integration of Wyeth's global operations in to Pfizer, while serving as senior vice-president of worldwide strategy and innovation.